We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$251M
AUM Growth
-$19M
Cap. Flow
-$2.24M
Cap. Flow %
-0.89%
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$785K
2
LHX icon
L3Harris
LHX
+$740K
3
A icon
Agilent Technologies
A
+$713K
4
CPRT icon
Copart
CPRT
+$688K
5
CQP icon
Cheniere Energy
CQP
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 18.83%
2 Real Estate 17.55%
3 Materials 12.77%
4 Financials 9.88%
5 Energy 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVIR icon
426
Atea Pharmaceuticals
AVIR
$367M
$89K 0.04%
15,660
+112
+0.7% +$857
ABUS icon
427
Arbutus Biopharma
ABUS
$861M
$82K 0.03%
42,988
+313
+0.7% +$737
VXRT
428
DELISTED
Vaxart
VXRT
$81K 0.03%
37,175
+271
+0.7% +$935
ATRA icon
429
Atara Biotherapeutics
ATRA
$73.7M
$77K 0.03%
810
+6
+0.7% +$674
CDXS icon
430
Codexis
CDXS
$162M
$71K 0.03%
11,779
+88
+0.8% +$708
FHTX icon
431
Foghorn Therapeutics
FHTX
$292M
$71K 0.03%
8,258
+60
+0.7% +$772
NUVB icon
432
Nuvation Bio
NUVB
$2.34B
$68K 0.03%
30,450
+216
+0.7% +$617
CVAC
433
DELISTED
CureVac
CVAC
$61K 0.02%
7,733
+57
+0.7% +$665
NVAX icon
434
Novavax
NVAX
$1.23B
$49K 0.02%
2,693
+14
+0.5% +$607
NBP
435
NovaBridge Biosciences American Depositary Shares
NBP
$193M
$46K 0.02%
11,531
+85
+0.7% +$645
LONA
436
LeonaBio Inc
LONA
$66.9M
$39K 0.02%
1,301
+10
+0.8% +$345
A icon
437
Agilent Technologies
A
$39.7B
-6,007
Closed -$713K
AKAM icon
438
Akamai
AKAM
$16.1B
-6,274
Closed -$573K
AMAT icon
439
Applied Materials
AMAT
$370B
-6,502
Closed -$592K
AME icon
440
Ametek
AME
$55B
-5,691
Closed -$625K
AMZN icon
441
Amazon
AMZN
$2.5T
-5,064
Closed -$538K
ARE icon
442
Alexandria Real Estate Equities
ARE
$9.48B
-3,772
Closed -$547K
ARES icon
443
Ares Management
ARES
$28.4B
-9,698
Closed -$551K
BRW
444
Saba Capital Income & Opportunities Fund
BRW
$337M
-50,372
Closed -$404K
CBRE icon
445
CBRE Group
CBRE
$44.2B
-8,695
Closed -$640K
CPRT icon
446
Copart
CPRT
$28.7B
-25,328
Closed -$688K
CSCO icon
447
Cisco
CSCO
$457B
-14,258
Closed -$608K
DOV icon
448
Dover
DOV
$26.9B
-5,218
Closed -$633K
DXCM icon
449
DexCom
DXCM
$29.2B
-6,365
Closed -$474K
EFX icon
450
Equifax
EFX
$22B
-3,711
Closed -$678K

Similar funds

Virtus ETF Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Virtus ETF Advisers held 477 positions worth $251M, down 7% from $270M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Virtus ETF Advisers's Q3 2022 filing shows 43 new, 256 increased, 137 reduced and 41 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K. The largest sale was Moderna, an estimated $785K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.

  • Virtus ETF Advisers's largest Q3 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K.
  • Virtus ETF Advisers added most to The Mosaic Company in Q3 2022, an estimated $962K increase.
  • Virtus ETF Advisers's biggest Q3 2022 reduction was Moderna, cutting an estimated $785K.
  • Virtus ETF Advisers fully exited L3Harris in Q3 2022, selling an estimated $740K.
  • Virtus ETF Advisers's ten largest holdings make up 7.1% of its $251M portfolio in Q3 2022.
  • Virtus ETF Advisers opened 43 new positions and closed 41 in Q3 2022.
  • Virtus ETF Advisers's portfolio value fell 7% quarter-over-quarter to $251M.

Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.